BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1357217)

  • 21. Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
    Forsyth KM; Bjur RA; Westfall DP
    J Pharmacol Exp Ther; 1991 Mar; 256(3):821-6. PubMed ID: 1672377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented responsiveness to sympathetic nerve stimulation of isolated vas deferens of diabetic rats.
    Wang YT; Takiguchi Y; Uematsu T; Nakashima M
    Arch Int Pharmacodyn Ther; 1991; 309():160-9. PubMed ID: 1653561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.
    Driessen B; von Kügelgen I; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):42-8. PubMed ID: 7935853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156.
    Westfall TD; Kennedy C; Sneddon P
    Br J Pharmacol; 1996 Mar; 117(5):867-72. PubMed ID: 8851503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of postjunctional purinergic mechanisms in the facilitatory action of bradykinin in neurotransmission in the rat vas deferens.
    Donoso MV; Huidobro-Toro JP
    Eur J Pharmacol; 1989 Jan; 160(2):263-73. PubMed ID: 2547629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of vasopressor and vas deferens responses by alpha,beta-methylene ATP in the pithed rat.
    Bulloch JM; McGrath JC
    Br J Pharmacol; 1988 May; 94(1):103-8. PubMed ID: 2900035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.
    Driessen B; Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Feb; 108(2):443-7. PubMed ID: 8383564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurokinin A suppresses a voltage-gated K+ current in smooth muscle cells from rat vas deferens.
    Nakazawa K; Inoue K; Fujimori K; Takanaka A
    Eur J Pharmacol; 1990 Jun; 182(1):189-92. PubMed ID: 1698161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens.
    von Kügelgen I; Kurz K; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):125-32. PubMed ID: 7909584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prejunctionally mediated inhibition of neurotransmission by isoprenaline in rat vas deferens.
    Huang Y; Lau CW; Chan NW; Yao XQ; Chan FL
    Life Sci; 1998; 63(23):2107-13. PubMed ID: 9839534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens.
    Lee CM
    Br J Pharmacol; 1985 Nov; 86(3):671-6. PubMed ID: 2998523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y (NPY), an endogenous presynaptic modulator of adrenergic neurotransmission in the rat vas deferens: structural and functional studies.
    Donoso V; Silva M; St-Pierre S; Huidobro-Toro JP
    Peptides; 1988; 9(3):545-53. PubMed ID: 2843832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inhibitory effect of ethanol on adrenergic neuromuscular transmission in the guinea-pig vas deferens.
    Takeda R; Momose Y
    Jpn J Pharmacol; 1983 Aug; 33(4):757-64. PubMed ID: 6314009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
    Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A
    Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The actions of cirazoline on the rat vas deferens.
    Docherty JR; McGrath JC
    Br J Pharmacol; 1984 May; 82(1):9-14. PubMed ID: 6145469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.
    Kurz K; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Dec; 110(4):1465-72. PubMed ID: 8306088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
    Major TC; Weishaar RE; Taylor DG
    Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin modulation of neuroeffector transmission in rat and guinea pig vas deferens.
    Wiklund NP; Ohlén A; Wiklund CU; Hedqvist P; Gustafsson LE
    Eur J Pharmacol; 1990 Aug; 185(1):25-33. PubMed ID: 2171959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.